Skip to main content

Table 3 Vaccination coverage ascertained by vaccination card or medical records among 641 surveyed children aged 12–71 months (weighted), by birth cohort, Bolivar, Venezuela, 2011

From: Vaccination Week in the Americas, 2011: an opportunity to assess the routine vaccination program in the Bolivarian Republic of Venezuela

Vaccine dose (recommended age) 12-23 months (n = 129) 24 – 35 months (n = 131) 36 - 47 months (n = 141) 48 – 59 months (n = 139) 60 - 71 months (n = 101)
No (%) [95% CI] who received dose No (%) [95% CI] who received dose No (%) [95% CI] who received dose No (%) [95% CI] who received dose No (%) [95% CI] who received dose
BCG (birth) 123 (95) [89–98] 126 (96) [91–98] 139 (99) [94- > 99] 136 (98) [93–99] 99 (98) [93–99]
Hepatitis B* (birth) 112 (87) [81–91] 106 (81) [71–88] 131 (93) [86–97] 127 (92) [83–96] 86 (85) [77–91]
Penta3* (6 months) 117 (91) [85–94] 121 (92) [86–96] 127 (90) [83–94] 137 (99) [94- >99] 93 (92) [85–96]
OPV3 (6 months) 111 (86) [78–91] 121 (92) [86–96] 126 (89) [82–94] 133 (96) [91–98] 93 (92) [81–97]
MMR1* (12 months) 94 (72) [63–80] 116 (89) [81–94] 128 (91) [79–96] 129 (93) [85–97] 89 (88) [77–94]
Yellow fever* (12 months) 81 (62) [54–70] 107 (82) [75–87] 130 (92) [86–96] 132 (95) [88–98] 94 (93) [87–97]
Rotavirus2* (4–8 months) 67 (51) [41–62] 68 (52) [43–60] 53 (38) [28–48] 38 (27) [19–36] 21 (21) [14–29]
DTP booster1* (18 months) N/A N/A N/A 33 (59) [52–66] 87 (61) [48–73] 103 (74) [62–83] 78 (77) [67–85]
OPV booster1* (18 months) N/A N/A N/A 84 (64) [55–72] 91 (64) [57–75] 113 (81) [69–90] 80 (79) [66–88]
DTP booster2 (5 years) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 17 (17) [10–27]
OPV booster2 (5 years) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 34 (34) [22–47]
MMR2 (5 years) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 27 (27) [18–37]
  1. *p value <0.05 indicates a difference in coverage between birth cohorts for given vaccine dose.